Enhanced recovery after surgery in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: national survey of peri-operative practice by Indian society of peritoneal surface malignancies

Author:

Somashekhar Sampige Prasanna1,Deo Suryanarayana2,Thammineedi Subramanyeshwar Rao3,Chaturvedi Harit4,Mandakukutur Subramanya Ganesh5,Joshi Rama6,Kothari Jagdish7,Srinivasan Ayyappan8,Rohit Kumar C.1,Ray Mukurdipi2,Prajapati Bharat7,Guddahatty Nanjappa Hemanth5,Ramalingam Rajagopalan3,Fernandes Aaron1,Ashwin Kyatsandra Rajagopal1

Affiliation:

1. Aster International Institute of Oncology , Aster hospital , Bengaluru , India

2. Department of Surgical Oncology , All India Institute of Medical Sciences , New Delhi , India

3. Surgical Oncology , Basavatarakam Indo-American Cancer Hospital and Research Institute , Hyderabad , India

4. Max Institute of Cancer care , New Delhi , India

5. Vydehi Institute of Medical Sciences and Research Centre , Bengaluru , India

6. Gynaecological Oncology , Fortis Memorial Research Institute, Gurgaon , New Delhi , India

7. HCG Cancer Centre Ahmedabad , Ahmedabad , India

8. Apollo Hospitals, Chennai , India

Abstract

Abstract Objectives The Enhanced recovery after surgery (ERAS) program is designed to achieve faster recovery by maintaining pre-operative organ function and reducing stress response following surgery. A two part ERAS guidelines specific for Cytoreductive surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) was recently published with intent of extending the benefit to patients with peritoneal surface malignancies. This survey was performed to examine clinicians’ knowledge, practice and obstacles about ERAS implementation in patients undergoing CRS and HIPEC. Methods Requests to participate in survey of ERAS practices were sent to 238 members of Indian Society of Peritoneal Surface malignancies (ISPSM) via email. They were requested to answer a 37-item questionnaire on elements of preoperative (n=7), intraoperative (n=10) and postoperative (n=11) practices. It also queried demographic information and individual attitudes to ERAS. Results Data from 164 respondents were analysed. 27.4 % were aware of the formal ERAS protocol for CRS and HIPEC. 88.4 % of respondents reported implementing ERAS practices for CRS and HIPEC either, completely (20.7 %) or partially (67.7 %). The adherence to the protocol among the respondents were as follows: pre operative (55.5–97.6 %), intra operative (32.6–84.8 %) and post operative (25.6–89 %). While most respondents considered implementation of ERAS for CRS and HIPEC in the present format, 34.1 % felt certain aspects of perioperative practice have potential for improvement. The main barriers to implementation were difficulty in adhering to all elements (65.2 %), insufficient evidence to apply in clinical practice (32.4 %), safety concerns (50.6 %) and administrative issues (47.6 %). Conclusions Majority agreed the implementation of ERAS guidelines is beneficial but are followed by HIPEC centres partially. Efforts are required to overcome barriers like improving certain aspects of perioperative practice to increase the adherence, confirming the benefit and safety of protocol with level I evidence and solving administrative issues by setting up dedicated multi-disciplinary ERAS teams.

Publisher

Walter de Gruyter GmbH

Subject

Oncology,Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3